Horizon Pharma plc Business Operations Contracts & Agreements
60 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Development Agreements (4)
- Distribution Agreements (7)
- Indemnification Agreements (3)
- Sales Agreements (1)
- Services Agreements (6)
- Settlement Agreements (7)
- Supply Agreements (30)
- Amendment No. 4 to Commercial Supply Agreement, dated May 31, 2022, by and between AGC Biologics A/S (formerly known as CMC Biologics A/S) and Horizon Therapeutics Ireland DAC (Filed With SEC on August 3, 2022)
- Master Manufacturing Services Agreement, dated October 15, 2018, by and between Patheon Pharmaceuticals Inc. and Horizon Medicines LLC (Filed With SEC on March 1, 2022)
- Settlement Agreement and First Amendment to License Agreement, dated August 21, 2007, by and among Saul Brusilow, M.D., Brusilow Enterprises, Inc., and Horizon Therapeutics, LLC... (Filed With SEC on February 24, 2021)
- API Supply Agreement, dated November 3, 2010, by and between Cambrex Profarmaco Milano and Horizon Therapeutics Ireland DAC (as successor in interest to Raptor Therapeutics Inc.... (Filed With SEC on November 2, 2020)
- Development and Manufacturing Services Agreement, dated June 10, 2015, by and between AGC Biologics A/S (formerly known as CMC Biologics A/S) and Horizon Therapeutics Ireland DAC... (Filed With SEC on November 2, 2020)
- Amendment No. 3 to Commercial Supply Agreement, dated July 30, 2020, by and between AGC Biologics A/S (formerly known as CMC Biologics A/S) and Horizon Therapeutics Ireland DAC (Filed With SEC on November 2, 2020)
- Amendment to Supply Agreement, effective as of November 30, 2018, by and between NOF Corporation and Horizon Therapeutics Ireland DAC (Filed With SEC on February 26, 2020)
- Amendment No. 2 to API Supply Agreement, effective as of January 17, 2018, by and between Cambrex Profarmaco Milano and Horizon Therapeutics Ireland DAC (Filed With SEC on February 26, 2020)
- Amendment No. 2 to Commercial Supply Agreement, dated December 18, 2019, by and between AGC Biologics A/S (formerly known as CMC Biologics A/S) and Horizon Therapeutics Ireland DAC (Filed With SEC on February 26, 2020)
- Mutual Settlement, Release and Media License Agreement, effective as of December 21, 2016, by and between River Vision Development Corp. and Boehringer Ingelheim... (Filed With SEC on November 6, 2019)
- Amendment No. 1 to Commercial Supply Agreement, dated May 15, 2019, by and between AGC Biologics A/S (formerly known as CMC Biologics A/S) and Horizon Pharma Ireland Limited (Filed With SEC on August 7, 2019)
- Commercial Supply Agreement, effective as of December 18, 2018, by and between Catalent Indiana, LLC and Horizon Pharma Ireland Limited (Filed With SEC on May 8, 2019)
- Commercial Supply Agreement, effective as of February 14, 2018, by and between CMC Biologics A/S, dba AGC Biologics and Horizon Pharma Ireland Limited (Filed With SEC on May 8, 2019)
- Confidential Settlement and License Agreement, effective as of September 17, 2018, by and between Horizon Therapeutics, LLC and Par Pharmaceutical, Inc (Filed With SEC on November 7, 2018)
- Letter Agreement, dated May 1, 2018, by and between Horizon Pharma USA, Inc. and Sanofi US Services, Inc (Filed With SEC on August 8, 2018)
- Confidential Settlement and License Agreement, effective as of June 27, 2018, by and among Horizon Therapeutics, LLC, Lupin Ltd. and Lupin Pharmaceuticals, Inc (Filed With SEC on August 8, 2018)
- Third Amendment to Supply Agreement, dated February 16, 2018, by and between Horizon Pharma Ireland Limited and Nuvo Pharmaceuticals Inc. (formerly known as Nuvo Research Inc.) (Filed With SEC on February 28, 2018)
- Second Amendment to Supply Agreement, dated January 1, 2017, by and between Horizon Pharma Ireland Limited and Nuvo Pharmaceuticals Inc. (formerly known as Nuvo Research Inc.) (Filed With SEC on February 28, 2018)
- AMENDMENT NO. 1 TO SALES CONTRACT (Filed With SEC on February 27, 2017)
- CONFIDENTIAL SETTLEMENT AGREEMENT AND MUTUAL RELEASE (Filed With SEC on November 7, 2016)
- Manufacturing Services Agreement November 15, 2010 (Filed With SEC on November 7, 2016)
- API SUPPLY AGREEMENT (Filed With SEC on November 7, 2016)
- FIFTH AMENDMENT TO COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on November 7, 2016)
- COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on August 8, 2016)
- COMMERCIAL SUPPLY AGREEMENT between SAVIENT PHARMACEUTICALSINC. and BIO-TECHNOLOGYGENERAL (ISRAEL) LTD. COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on August 8, 2016)
- Amendment No. 2 (hereinafter the Amendment No. 2) to the Consolidated Supply Agreement effective 31 July 2013, (hereinafter the AGREEMENT) (Filed With SEC on August 8, 2016)
- CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on November 6, 2015)
- THIRD AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Filed With SEC on August 7, 2015)
- CONFIDENTIAL SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on August 7, 2015)
- MANUFACTURING AND SUPPLY AGREEMENT - AMENDMENT No. 3 (Filed With SEC on February 27, 2015)
- EXCLUSIVE DISTRIBUTION AGREEMENT - AMENDMENT No. 3 (Filed With SEC on February 27, 2015)
- CONSOLIDATED SUPPLY AGREEMENT (Filed With SEC on February 27, 2015)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 19, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on September 19, 2014)
- Master Manufacturing Services Agreement October 31, 2013 (Filed With SEC on March 13, 2014)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT FOR THE UNITED STATES (Filed With SEC on March 13, 2014)
- AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT FOR THE UNITED STATES by and between POZEN INC. and ASTRAZENECA AB November 18, 2013 (Filed With SEC on March 13, 2014)
- SUPPLY AGREEMENT (Filed With SEC on March 13, 2014)
- MANUFACTURING AND SUPPLY AGREEMENT AMENDMENT No. 2 (Filed With SEC on March 13, 2014)
- EXCLUSIVE DISTRIBUTION AGREEMENT AMENDMENT No. 2 (Filed With SEC on March 13, 2014)
